Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 8Neoplasm Metastasis 7Multiple Myeloma 6Prostatic Neoplasms 5Pain 3Uterine Cervical Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Bone Neoplasms 2Uterine Cervical Dysplasia 1Urologic Neoplasms 1Small Cell Lung Carcinoma 1Precancerous Conditions 1Pleural Effusion, Malignant 1Osteoporosis 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm, Residual 1Lung Neoplasms 1Kidney Neoplasms 1Humoral Hypercalcemia Of Malignancy 1Hematologic Neoplasms 1Giant Cell Tumors of Bone 1Giant Cell Tumor of Bone 1Disease Progression 1Carcinoma, Ductal, Breast 1Breast Neoplasms, Male 1Bone Diseases, Metabolic 1Adenocarcinoma 1

Interventions

Cyclophosphamide 9fludarabine 8Interleukin-2 8aldesleukin 7Sunitinib 6Everolimus 6Bevacizumab 6fludarabine phosphate 5Sorafenib 5Radiotherapy 4Nivolumab 4Gene Expression Profiling 4Filgrastim 4pembrolizumab 3peginterferon alfa-2b 3Stem Cell Transplantation 3Radiotherapy, Intensity-Modulated 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Immunohistochemistry 3Granulocyte Colony-Stimulating Factor 3cabozantinib 2atezolizumab 2Thiotepa 2Sodium Chloride 2Reverse Transcriptase Polymerase Chain Reaction 2Polymerase Chain Reaction 2Mycophenolic Acid 2Mesna 2Immunoenzyme Techniques 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Kidney Neoplasms × Zoledronic Acid × Clear all
NCT00582790 2019-11-25

Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer

University of Wisconsin, Madison

Phase 2 Terminated
12 enrolled 8 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡